Clinical Trials

Showing trials with last updates posted in 2025.

NCT05919693 | COMPLETED | PHASE1/PHASE2
33 participants

A 2-part Study Consisting of Multiple Ascending Dose (MAD) Safety Study, and a Dose-finding Masked Study to Assess the Safety and Efficacy of Intravitreal (IVT) EYE103 in Patients With Diabetic Macular Edema (DME) or Neovascular Age-related Macular Degeneration (NVAMD)

Study Type:
INTERVENTIONAL
Last Updated:
2025-11-20
Start Date:
2023-06-12
Completion:
2024-08-26
Conditions
  • Neovascular Age-related Macular Degeneration (NVAMD)
  • Diabetic Macular Edema (DME)
Interventions
  • DRUG
No Results Yet
NCT05768880 | ACTIVE_NOT_RECRUITING | PHASE1
72 participants

Study of B7-H3, EGFR806, HER2, And IL13-Zetakine (Quad) CAR T Cell Locoregional Immunotherapy For Pediatric Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, And Recurrent Or Refractory Central Nervous System Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2025-11-20
Start Date:
2023-05-05
Completion:
2028-01-15
Conditions
  • Diffuse Intrinsic Pontine Glioma
  • Diffuse Midline Glioma
  • Recurrent CNS Tumor, Adult
  • Recurrent, CNS Tumor, Childhood
  • Refractory Primary Malignant Central Nervous System Neoplasm
Interventions
  • BIOLOGICAL
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page